FDA Accepts Camurus’ Resubmitted NDA for CAM2029 in Acromegaly Endocrinology Advisor 14:36 Tue, 21 Jul
Camurus' NDA resubmission for CAM2029 in acromegaly accepted for review by the US FDA PR Newswire (Press Release) 06:26 Fri, 17 Jul
FDA advisers dismiss safety warnings, back 4 peptide treatments Dermatology Advisor 2d Pharma Health All sources
FDA AdCom shuns Capricor’s DMD cell therapy amid data dispute Pharmaceutical Technology 9h Capricor Therapeutics Duchenne Pharma All sources
‘Be realistic, we’re in India’: Bombay High Court quashes suspension of hotel licence by FDA over hygiene The Hindu 15h Mumbai India Article paywall All sources
FDA approves first OTC acetaminophen/Naproxen Sodium fixed-dose tablet Renal and Urology News 2d Tylenol Pharma All sources
